Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
CapitalCell logo — Invierte en las empresas biomédicas validadas por los mejore...

CapitalCell

Invierte en las empresas biomédicas validadas por los mejores especialistas

Founded 2014 Spain Spain 28 employees Debt Financing Total: $1.69M Biotechnology, Fintech +3

General Information

Company Name CapitalCell
Founded Year 2014
Location Spain Spain +2
Founders / Decision Makers
Team member
Employees 28
Industries Biotechnology, Fintech, Life Sciences +2
Funding Stage Debt Financing
Social

Get notified when CapitalCell moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CapitalCell

CapitalCell is a pan-European crowdinvesting platform focused on biotech & Life Sciences companies, established in 2014. Boasting a unique approach that combines traditional venture capital, business angels, accredited investors, and the power of the Crowd, Capital Cell has positioned itself as a global meeting point for companies and researchers shaping the future of medical science. Their platform serves as a health & biotech marketplace where investors, regardless of their scale, can participate in equity-crowdfunding for non-listed companies. Notably, the platform provides investors with the most accurate scientific and financial information about each project, ensuring transparency and thorough due diligence. The company's slogan, "Invierte en las empresas biomédicas validadas por los mejores especialistas," reflects their commitment to validated biomed companies by top specialists. Headquartered in Spain, CapitalCell recently secured a significant €450.00K Debt Financing investment on 23 January 2024, with participation from John Bethell and ENISA. With its focus on Biotechnology, Fintech, and Pharmaceutical industries, this platform has the potential to continue shaping the future of investment in the life sciences sector, providing a unique gateway for both large and small-scale investors to engage in groundbreaking projects.

Taxonomy: equity-crowdfunding, biotech, life sciences, global investors, venture capitalists, business angels, accredited investors, medical science, health marketplace, financial data, researchers, companies, Europe, crowdinvesting, scientific data

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Equity Crowdfunding •••••• - 23 Jan 2024
Debt Financing •••••• 2 •••• •••• 23 Jan 2024
Equity Crowdfunding •••••• 5 •••• •••• 28 Apr 2018
Equity Crowdfunding •••••• 1 •••• •••• 23 Feb 2016

CapitalCell Alternatives & Competitors

CapitalCell vs
BIOTECanada
BIOTECanada Canada

Solving for today. Building for tomorrow.

27 employees
Agriculture, Biotechnology
Compare CapitalCell vs BIOTECanada
CapitalCell vs
Vator Securities
Vator Securities Sweden

Vator Securities advises growth companies as they expand and develop into tomorrow's market leaders.

33 employees
Financial Services
CapitalCell vs
GrowthPath Partners
GrowthPath Partners United States

Technical Accounting & Advisory Firm

4 employees
Financial Services
Compare CapitalCell vs GrowthPath Partners
Also compare with: CapitalCell vs Reshape Biotech Reshape Biotech

FAQ About CapitalCell

Invierte en las empresas biomédicas validadas por los mejores especialistas
CapitalCell was founded in 2014.
CapitalCell is headquartered in Spain.
CapitalCell operates in the following industries: Biotechnology, Fintech, Life Sciences, Medical Devices, Pharmaceutical.
CapitalCell has approximately 28 employees.
CapitalCell has completed 4 funding rounds, raising a total of $1.69M. The latest funding stage is Debt Financing.
Top alternatives and competitors to CapitalCell include BIOTECanada, Vator Securities, GrowthPath Partners, Reshape Biotech, Roots Analysis. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CapitalCell and BIOTECanada are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CapitalCell and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy